US issues travel alert as chikungunya cases surge abroad

The United States has updated its travel health guidance as chikungunya cases climb in several regions, prompting fresh warnings for Americans heading to parts of the Caribbean, Latin America, Africa and the Indian Ocean where the mosquito borne virus is circulating.

Regions seeing the biggest spikes in chikungunya

Publicly available data from international health agencies show that chikungunya transmission has intensified since late 2024, with sustained outbreaks reported across the Americas and in parts of the Indian Ocean and Asia. Regional monitoring in early 2026 indicates tens of thousands of suspected and confirmed infections in the first months of the year, underscoring a resurgence of the virus in areas where it had been relatively quiet in recent seasons.

In the Americas, the Pan American Health Organization has described a sustained increase in cases since late 2025, with higher activity in several South American and Caribbean countries. Localized outbreaks have been documented in nations such as Brazil, Paraguay and Argentina, alongside ongoing transmission in parts of Central America and island destinations popular with North American tourists.

Globally, World Health Organization updates identify active or recent outbreaks linked to the Indian Ocean basin, including island states with strong tourism sectors, as well as renewed circulation in parts of South and Southeast Asia. European surveillance reports have also logged infections among travelers returning from Indian Ocean destinations, highlighting how quickly the virus can move along major air routes.

US travel health advisories draw on this international reporting to flag higher risk for travelers heading to areas with documented outbreaks or seasonal spikes. While advisory language varies by country, destinations with recent clusters or sustained transmission are more likely to carry heightened alerts that emphasize mosquito protection and prompt medical attention for symptoms.

What chikungunya is and how it spreads

Chikungunya is a viral illness spread through the bite of infected Aedes mosquitoes, the same daytime biting insects that transmit dengue and Zika. These mosquitoes thrive in warm, humid climates and often breed in small collections of standing water in and around homes, hotels and urban areas, bringing them into close contact with people.

Health agencies describe chikungunya as an acute febrile disease that typically begins between three and seven days after a bite from an infected mosquito. The virus is not spread directly from person to person through casual contact, but an infected person can serve as a source of virus for mosquitoes during the first days of illness, which can then perpetuate local transmission.

Because Aedes mosquitoes are widely established in tropical and many subtropical regions, once the virus is introduced it can circulate rapidly, particularly where people have little prior immunity. International travel can bring infected individuals into new areas, and if competent mosquitoes are present, local outbreaks can follow.

For US travelers, the main risk is being bitten by infected mosquitoes while visiting an affected country and then developing symptoms during or shortly after the trip. Public health guidance focuses heavily on preventing mosquito bites and, in some cases, considering vaccination for certain higher risk travelers where vaccines are available and recommended under national policies.

Key symptoms travelers should watch for

Chikungunya usually begins suddenly with high fever, often accompanied by severe joint pain that can be debilitating. Official case descriptions frequently mention pain in the hands, wrists, ankles or feet, along with muscle aches, headache and marked fatigue. The combination of intense joint pain and fever is considered characteristic and helps distinguish chikungunya from some other mosquito borne infections.

A rash can appear in many patients, typically a few days after the onset of fever. Nausea, vomiting and conjunctivitis are also reported in some cases. Most people begin to feel better within about a week, but joint pain can linger for weeks or even months in a subset of patients, impacting mobility and daily activities long after the initial infection has resolved.

Severe disease is less common but can occur, particularly in older adults, newborns exposed around the time of birth, and people with underlying health conditions such as cardiovascular disease, diabetes or weakened immune systems. Complications described in medical literature include neurological symptoms, heart inflammation and eye problems, although these remain relatively rare compared with the overall number of infections.

Travel health agencies advise anyone who develops sudden fever and joint pain during or after travel to a chikungunya affected area to seek medical evaluation and to mention recent destinations. Early clinical assessment is important not only for supportive care but also to distinguish chikungunya from dengue, malaria and other conditions that may require different management.

How US travelers can reduce their risk

Current US guidance centers on rigorous mosquito bite prevention for anyone heading to regions with known chikungunya activity. Travelers are encouraged to use insect repellents containing active ingredients such as DEET, picaridin, IR3535 or oil of lemon eucalyptus, applied according to product instructions, and to reapply as directed, especially in hot or humid conditions that can reduce effectiveness.

Wearing long sleeved shirts, long trousers and closed shoes can create a physical barrier against mosquito bites, particularly during daylight hours when Aedes mosquitoes are most active. Light colored clothing is often recommended because it can make it easier to spot mosquitoes and may attract fewer insects than dark garments.

Accommodation choices also play a role. Rooms with air conditioning, well fitting screens on windows and doors, or bed nets can reduce exposure, especially in areas where electricity or screening may be unreliable. Travelers staying in guesthouses, rental homes or rural lodges are frequently encouraged to check for standing water in containers such as buckets, planters and roof gutters and to empty or cover them where possible.

For some individuals, vaccination may be an additional option. Regulatory authorities in several regions, including the United States, have authorized chikungunya vaccines for specific age groups, and expert groups continue to review how best to use them in the context of outbreaks and travel. Travelers who are pregnant, older, or have chronic health conditions are generally advised to consult a health professional well ahead of departure to discuss personal risk, the role of vaccination where available, and any other preventive measures.

Planning ahead before and after a trip

Health agencies recommend that travelers planning visits to affected regions review the latest country specific advisories before booking and again shortly before departure, as outbreak patterns can change within weeks. Pre travel consultations can help align itineraries with local risk levels, taking into account factors such as rural versus urban stays, time outdoors and planned activities.

Carrying a basic travel health kit with insect repellent, loose long clothing, oral rehydration solutions and fever reducing medication appropriate for the traveler’s age and health status can support self care if symptoms appear. Guidance typically discourages the use of certain medicines, such as non steroidal anti inflammatory drugs, until dengue and other conditions have been ruled out, so medical advice is important before self treating severe illness.

After returning home, travelers are advised to monitor their health for about two weeks. If fever, joint pain or rash develop, they should contact a medical provider and mention recent travel to chikungunya affected areas. Publicly available information notes that people with suspected chikungunya should continue using mosquito precautions for at least a week after symptoms start, in order to reduce the chance that local mosquitoes could pick up the virus and contribute to limited transmission.

Experts emphasize that with careful preparation, many trips can proceed safely even in the context of active chikungunya outbreaks. The evolving US travel advisories are intended to inform decisions and encourage protective behaviors, rather than to halt travel entirely, while global health agencies continue to track the virus and refine guidance as new data emerge.